The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126000631 12600063 1 I 20140903 20160727 20160727 EXP PHHY2014CA115548 NOVARTIS 0.00 F Y 48.00000 KG 20160727 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126000631 12600063 1 PS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 5 MG, UNK 21817 5 MG SOLUTION FOR INJECTION
126000631 12600063 2 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) UNK 21817 SOLUTION FOR INJECTION
126000631 12600063 3 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) UNK 21817 SOLUTION FOR INJECTION
126000631 12600063 4 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) UNK 21817 SOLUTION FOR INJECTION
126000631 12600063 5 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 21817 SOLUTION FOR INJECTION
126000631 12600063 6 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 21817 SOLUTION FOR INJECTION
126000631 12600063 7 SS ACLASTA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) UNK 21817 SOLUTION FOR INJECTION
126000631 12600063 8 C METHOTREXATE. METHOTREXATE 1 Unknown 2.5 MG, (4 TABLETS A WEEK) U 0 2.5 MG TABLET
126000631 12600063 9 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 Unknown 200 MG, 1 TABLET 5 X PER WEEK U 0 200 MG TABLET
126000631 12600063 10 C ARTHROTEC DICLOFENAC SODIUMMISOPROSTOL 1 Unknown 5 MG, QOD U 0 5 MG TABLET
126000631 12600063 11 C CIPRALEX ESCITALOPRAM OXALATE 1 Unknown 20 MG, QD U 0 20 MG QD
126000631 12600063 12 C PREVACID LANSOPRAZOLE 1 Unknown 30 MG, QD U 0 30 MG QD
126000631 12600063 13 C MEGA-CAL+D 2 Unknown 2 DF, PER DAY (500 MG PLUS 125 UG) U 0 2 DF TABLET
126000631 12600063 14 C VITAMIN B12 CYANOCOBALAMIN 1 Unknown U 0 TABLET
126000631 12600063 15 C FOLIC ACID. FOLIC ACID 1 Unknown 30 MG, QID EVERY DAY U 0 30 MG QID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126000631 12600063 1 Osteoporosis
126000631 12600063 8 Product used for unknown indication
126000631 12600063 9 Product used for unknown indication
126000631 12600063 10 Product used for unknown indication
126000631 12600063 11 Product used for unknown indication
126000631 12600063 12 Product used for unknown indication
126000631 12600063 13 Product used for unknown indication
126000631 12600063 14 Product used for unknown indication
126000631 12600063 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126000631 12600063 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126000631 12600063 Rheumatoid arthritis
126000631 12600063 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126000631 12600063 1 20090903 0
126000631 12600063 2 20100810 0
126000631 12600063 3 20110811 0
126000631 12600063 4 20120814 0
126000631 12600063 5 20130813 0
126000631 12600063 6 20140903 0
126000631 12600063 7 20150810 0